Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

NCT01457885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloblastic Leukemia

Interventions

DRUG: Clofarabine/Busulfan x 4
PROCEDURE: Peripheral blood stem cell transplant

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]